Author:
Manseck A.,Mansouri Taleghani B.,Wirth M.
Publisher
Springer Berlin Heidelberg
Reference23 articles.
1. Ackermann R (1988) Immunologische Aspekte in der Behandlung des Nierenkarzinoms. In: Staehler G (ed) Das Nierenkarzinom. Springer, Berlin Heidelberg New York Tokyo, S 104–114.
2. Atzpodien J (1990) Home therapy with recombinant interleukin-2 and interferon-α 2b in advanced human malignancies. Lancet 335:1509–1512.
3. Blay JY et al (1990) Correlation between clinical response to interleukin-2 therapy and sustained production of tumor necrosis factor. Cancer Res 50:2371–2374.
4. Bono AV (1986) Steroid hormones and hormonal treatment in renal cell carcinoma. In: DeKernion JB, Pavone Macaluso M (eds) Tumors of the kidney, vol 13. Williams & Wilkins, Baltimore, pp 205–227.
5. Budd TJ et al (1989) Phase I clinical trial of interleukin-2 and α-interferon: toxicity and immunologic effects. Cancer Res 49:6432–6436.